Sinha BK - Search Results

1

Inhibition of DNA repair and sensitization of cisplatin in human ovarian carcinoma cells by interleukin-1 alpha.

Benchekroun MN, Parker R, Reed E, Sinha BK. Benchekroun MN, et al. Among authors: sinha bk. Biochem Biophys Res Commun. 1993 Aug 31;195(1):294-300. doi: 10.1006/bbrc.1993.2044. Biochem Biophys Res Commun. 1993. PMID: 8363610

2

Effects of interleukin-1 alpha on DNA repair in human ovarian carcinoma (NIH:OVCAR-3) cells: implications in the mechanism of sensitization of cis-diamminedichloroplatinum(II).

Benchekroun MN, Parker R, Dabholkar M, Reed E, Sinha BK. Benchekroun MN, et al. Among authors: sinha bk. Mol Pharmacol. 1995 Jun;47(6):1255-60. Mol Pharmacol. 1995. PMID: 7603468

3

Potentiation of antitumor activities of carboplatin and camptothecin by interleukin-1 alpha against human ovarian carcinoma in vivo.

Wang Z, Benchekroun MN, Sinha BK. Wang Z, et al. Among authors: sinha bk. Anticancer Res. 1994 Sep-Oct;14(5A):1723-6. Anticancer Res. 1994. PMID: 7847805

4

Sensitization by interleukin-1alpha of carboplatinum anti-tumor activity against human ovarian (NIH:OVCAR-3) carcinoma cells in vitro and in vivo.

Wang Z, Lee KB, Reed E, Sinha BK. Wang Z, et al. Among authors: sinha bk. Int J Cancer. 1996 Nov 27;68(5):583-7. doi: 10.1002/(SICI)1097-0215(19961127)68:5<583::AID-IJC5>3.0.CO;2-V. Int J Cancer. 1996. PMID: 8938138

5

Mechanisms of resistance to ansamycin antibiotics in human breast cancer cell lines.

Benchekroun MN, Schneider E, Safa AR, Townsend AJ, Sinha BK. Benchekroun MN, et al. Among authors: sinha bk. Mol Pharmacol. 1994 Oct;46(4):677-84. Mol Pharmacol. 1994. PMID: 7969046

6

Synergistic antiproliferative effects of interleukin-1 alpha and doxorubicin against the human ovarian carcinoma cell line (NIH:OVCAR-3).

Monti E, Mimnaugh EG, Sinha BK. Monti E, et al. Among authors: sinha bk. Biochem Pharmacol. 1993 May 25;45(10):2099-107. doi: 10.1016/0006-2952(93)90022-o. Biochem Pharmacol. 1993. PMID: 8512591

7

Synergistic antiproliferative effects of the combination of interleukin-1 alpha and doxorubicin against human melanoma cells.

Mimnaugh EG, Monti E, Sebers S, Stetler-Stevenson M, Sinha BK. Mimnaugh EG, et al. Among authors: sinha bk. Oncol Res. 1992;4(10):401-12. Oncol Res. 1992. PMID: 1292755

8

A role for the interleukin 1 receptor in the synergistic antitumor effects of human interleukin 1 alpha and etoposide against human melanoma cells.

Usui N, Mimnaugh EG, Sinha BK. Usui N, et al. Among authors: sinha bk. Cancer Res. 1991 Feb 1;51(3):769-74. Cancer Res. 1991. PMID: 1824825

9

Synergistic interactions of etoposide and interleukin-1 alpha are not due to DNA damage in human melanoma cells.

Monti E, Mimnaugh EG, Sinha BK. Monti E, et al. Among authors: sinha bk. Biochim Biophys Acta. 1993 Jan 22;1180(3):231-5. doi: 10.1016/0925-4439(93)90043-z. Biochim Biophys Acta. 1993. PMID: 8422427

10

Doxorubicin-induced oxygen free radical formation in sensitive and doxorubicin-resistant variants of rat glioblastoma cell lines [corrected and republished erratum originally printed in FEBS Lett 1993 May 17;322(3):295-8].

Benchekroun MN, Sinha BK, Robert J. Benchekroun MN, et al. Among authors: sinha bk. FEBS Lett. 1993 Jul 12;326(1-3):302-5. doi: 10.1016/0014-5793(93)81815-h. FEBS Lett. 1993. PMID: 8392002 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

233 results

Search Page

Filters